Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$63.02 - $95.11 $16,889 - $25,489
-268 Closed
0 $0
Q2 2019

Jul 10, 2019

SELL
$25.78 - $39.77 $1,753 - $2,704
-68 Reduced 20.24%
268 $10,000
Q1 2019

Apr 12, 2019

SELL
$22.09 - $39.21 $2,142 - $3,803
-97 Reduced 22.4%
336 $11,000
Q3 2018

Nov 01, 2018

SELL
$12.1 - $28.85 $1,827 - $4,356
-151 Reduced 25.86%
433 $11,000
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $222 - $442
28 Added 5.04%
584 $10,000
Q4 2017

Feb 09, 2018

SELL
$3.98 - $7.37 $1,190 - $2,203
-299 Reduced 34.97%
556 $4,000
Q3 2017

Nov 14, 2017

BUY
$1.33 - $4.12 $1,137 - $3,522
855
855 $3,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.